Century Therapeutics to present CNTY-813 preclinical data at two fall congresses
Tweet Send to a Friend
Century Therapeutics (NASDAQ: IPSC) announced that preclinical data for its CNTY-813 program have been accepted for oral presentations at two ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
